BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25915414)

  • 1. Susceptibility-Weighted Imaging Manifestations in the Brain of Wilson's Disease Patients.
    Yang J; Li X; Yang R; Yu X; Yu C; Qian Y; Yu Y
    PLoS One; 2015; 10(4):e0125100. PubMed ID: 25915414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep-gray nuclei susceptibility-weighted imaging filtered phase shift in patients with Wilson's disease.
    Bai X; Wang G; Wu L; Liu Y; Cui L; Shi H; Guo L
    Pediatr Res; 2014 Mar; 75(3):436-42. PubMed ID: 24477071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing brain mineral deposition in patients with Wilson disease using susceptibility-weighted imaging.
    Zhou XX; Qin HL; Li XH; Huang HW; Liang YY; Liang XL; Pu XY
    Neurol India; 2014; 62(4):362-6. PubMed ID: 25237939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic Susceptibility Changes in the Basal Ganglia and Brain Stem of Patients with Wilson's Disease: Evaluation with Quantitative Susceptibility Mapping.
    Doganay S; Gumus K; Koc G; Bayram AK; Dogan MS; Arslan D; Gumus H; Gorkem SB; Ciraci S; Serin HI; Coskun A
    Magn Reson Med Sci; 2018 Jan; 17(1):73-79. PubMed ID: 28515413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics of patients with delayed hepatolenticular degeneration].
    Zhou XX; Qin HL; He RX; Chen DB; Wu C; Feng L; Li XH; Liang XL
    Zhonghua Nei Ke Za Zhi; 2019 Jul; 58(7):501-507. PubMed ID: 31269566
    [No Abstract]   [Full Text] [Related]  

  • 6. Brain susceptibility changes in neurologically asymptomatic pediatric patients with Wilson's disease: evaluation with quantitative susceptibility mapping.
    Saracoglu S; Gumus K; Doganay S; Koc G; Kacar Bayram A; Arslan D; Gumus H
    Acta Radiol; 2018 Nov; 59(11):1380-1385. PubMed ID: 29482344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The asymmetry of neural symptoms in Wilson's disease patients detecting by diffusion tensor imaging, resting-state functional MRI, and susceptibility-weighted imaging.
    Zhou XX; Li XH; Chen DB; Wu C; Feng L; Chu JP; Yang ZY; Li XB; Qin H; Li GD; Huang HW; Liang YY; Liang XL
    Brain Behav; 2018 May; 8(5):e00930. PubMed ID: 29761003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole brain volume and cortical thickness abnormalities in Wilson's disease: a clinical correlation study.
    Song Y; Zou L; Zhao J; Zhou X; Huang Y; Qiu H; Han H; Yang Z; Li X; Tang X; Chu J
    Brain Imaging Behav; 2021 Aug; 15(4):1778-1787. PubMed ID: 33052506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cranial MR imaging in Wilson's disease.
    King AD; Walshe JM; Kendall BE; Chinn RJ; Paley MN; Wilkinson ID; Halligan S; Hall-Craggs MA
    AJR Am J Roentgenol; 1996 Dec; 167(6):1579-84. PubMed ID: 8956601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilson's disease tremor is associated with magnetic resonance imaging lesions in basal ganglia structures.
    Südmeyer M; Saleh A; Wojtecki L; Cohnen M; Gross J; Ploner M; Hefter H; Timmermann L; Schnitzler A
    Mov Disord; 2006 Dec; 21(12):2134-9. PubMed ID: 17044091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paramagnetic Metal Accumulation in the Deep Gray Matter Nuclei Is Associated With Neurodegeneration in Wilson's Disease.
    Yuan XZ; Li GY; Chen JL; Li JQ; Wang XP
    Front Neurosci; 2020; 14():573633. PubMed ID: 33041766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Difference in imaging and metal metabolism between hepatic and cerebral type Wilson disease].
    Zhou XX; Li XH; Pu XY; Qin HL; Li XB; Chu JP; Yang ZY; Huang HW; Liang XL
    Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(3):176-181. PubMed ID: 28162166
    [No Abstract]   [Full Text] [Related]  

  • 13. Regional morphometric abnormalities and clinical relevance in Wilson's disease.
    Zou L; Song Y; Zhou X; Chu J; Tang X
    Mov Disord; 2019 Apr; 34(4):545-554. PubMed ID: 30817852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seven-tesla magnetic resonance imaging in Wilson disease using quantitative susceptibility mapping for measurement of copper accumulation.
    Fritzsch D; Reiss-Zimmermann M; Trampel R; Turner R; Hoffmann KT; Schäfer A
    Invest Radiol; 2014 May; 49(5):299-306. PubMed ID: 24220252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in brain susceptibility in Wilson's disease patients: a quantitative susceptibility mapping study.
    Deng W; Zhang J; Yang J; Wang Z; Pan Z; Yue X; Zhao R; Qian Y; Yu Y; Li X
    Clin Radiol; 2024 Feb; 79(2):e282-e286. PubMed ID: 38087682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive Pattern of Metal Deposition in Neurologic Wilson Disease: Insights From 7T Susceptibility-Weighted Imaging.
    Su D; Zhang Z; Zhang Z; Zheng S; Yao T; Dong Y; Zhu W; Wei N; Suo Y; Liu X; Zhao H; Wang Z; Ma H; Li W; Zhou J; Lam JST; Wu T; Dusek P; Stoessl AJ; Wang X; Jing J; Feng T
    Neurology; 2024 Jun; 102(12):e209478. PubMed ID: 38830145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on Lesion Assessment of Cerebello-Thalamo-Cortical Network in Wilson's Disease with Diffusion Tensor Imaging.
    Wang A; Wu H; Xu C; Tang L; Lee J; Wang M; Jiang M; Li C; Lu Q; Zhang C
    Neural Plast; 2017; 2017():7323121. PubMed ID: 28781902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain metal accumulation in Wilson's disease.
    Litwin T; Gromadzka G; Szpak GM; Jabłonka-Salach K; Bulska E; Członkowska A
    J Neurol Sci; 2013 Jun; 329(1-2):55-8. PubMed ID: 23597670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of Brain Atrophy and Cerebral Iron Accumulation at MRI with Clinical Severity in Wilson Disease.
    Dusek P; Lescinskij A; Ruzicka F; Acosta-Cabronero J; Bruha R; Sieger T; Hajek M; Dezortova M
    Radiology; 2021 Jun; 299(3):662-672. PubMed ID: 33754827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI - histopathological study.
    Dusek P; Bahn E; Litwin T; Jabłonka-Salach K; Łuciuk A; Huelnhagen T; Madai VI; Dieringer MA; Bulska E; Knauth M; Niendorf T; Sobesky J; Paul F; Schneider SA; Czlonkowska A; Brück W; Wegner C; Wuerfel J
    Neuropathol Appl Neurobiol; 2017 Oct; 43(6):514-532. PubMed ID: 27543917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.